Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-alpha: a Cancer and Leukemia Group B study.

International journal of oncology

Volumn 25, Issue 1, 2004, Pages 143-151

  Farag, Sherif S ^a   Ruppert, Amy S ^a   Mrózek, Krzysztof ^a   Carroll, Andrew J ^a   Pettenati, Mark J ^a   Le Beau, Michelle M ^a   Peterson, Bercedis L ^a   Powell, Bayard L ^a   Ozer, Howard ^a   Silver, Richard T ^a   Larson, Richard A ^a   Bloomfield, Clara D ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENETICS; HUMAN; KARYOTYPING; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MYELOID LEUKEMIA; PROGNOSIS; SURVIVAL; TIME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 21644490136     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)